Acting US FDA Chief Scientist Tapped, As Borio Moves To White House Biodefense Detail
Executive Summary
FDA promotes Denise Hinton to acting chief scientist after Luciana Borio is detailed to the National Security Council for biodefense work
You may also be interested in...
US Officials: Work On Tests To Discern Zika From Dengue Could Slow Without Steady Federal Funding
Scientists from US FDA and other health agencies are working to develop and rapidly approve tests that can clearly and quickly detect Zika virus from Dengue fever. But without a steady source of funding for countermeasures, progress to fight Zika may slow, even while the emergence of mosquito-borne diseases accelerates, agency officials said.
Assurance Vs. Flexibility: Unit-Of-Use Packaging Offers Trade-Offs For Patient Leaflets
Manufacturers would have full responsibility for writing, producing, and ultimately delivering the new patient medication information document with their products, if FDA decides the industry should fully adopt the unit-of-use packaging.
As COVID Public Health Emergency Winds Down, US FDA Employs Flexibility For Rx EUA Transitions
Biden administration sets May 11 as end date for public health emergency. CDER has said it will work with sponsors to help them gain approval of COVID therapeutics cleared under emergency use authorizations, but agency will likely not issue a formal transition framework.